Contribution
It is a pleasure to serve under your chairship, Mr Betts. I thank the hon. Member for Leicester East (Shivani Raja) for securing this important debate. I declare an interest as a vice-chair of the APPG on pharmacy, my colleague on which, the hon. Member for North Somerset (Sadik Al-Hassan), I am happy to follow.
For many residents in rural constituencies such as mine, local pharmacies are the first, and often only, point of contact with the NHS. Longer distances to travel, limited public transport and patchy digital connectivity mean that the trusted and timely in-person service that they provide for our communities is vital. However, access is thin on the ground.
Analysis by the National Pharmacy Association has described west Berkshire as England’s “pharmacy desert”, with the lowest number of pharmacies per head of any council area. To put that in context, the UK average is about one pharmacy to every 4,600 patients; in my constituency, it is one to every 7,200. Twelve pharmacies still open their doors to residents across Newbury and west Berkshire, and they do essential, extraordinary work. They dispense more than 111,000 prescriptions every month and deliver enough consultations through Pharmacy First to save more than 8,000 GP appointments, all while acting as a specialist and friendly front door to our NHS.
Like many here, I welcome the Government’s recent investment in the sector. We have heard the cash figures, but the 10.3% uplift for 2026-27 is the largest increase anywhere in primary care this year, and the move to expand prescribing rights is a vital step in the right direction. However, a positive uplift does not in isolation deliver the sustainable settlements that pharmacies desperately need. Pharmacies cannot plan their workforce or their services throughout the year when settlements are negotiated and have to be fought for year by year. Nationally, we have lost over 1,300 pharmacies since 2016, and this year’s uplift will not plug the underlying funding gap, which now stands at over £2 billion. It is no wonder that Community Pharmacy England accepted this year’s deal on the condition of further reform, stating clearly:
“Accepting this deal does not mean we think it is enough”.
With budgets stretched, that instability is compounded by broken medicine supply chains and a framework that leaves many pharmacies in the impossible position of dispensing medicines at a loss. On visits to Lambourn pharmacy and MedWell chemist in Newbury, staff told me that current funding would quickly be absorbed by rocketing drug prices, with some pharmacies paying 14 to 15 times more for prescription medicine than at the start of the year. In rural areas, where proximity to provision is already paramount, older residents in particular cannot afford to lose access to their prescription because their pharmacy down the road has been priced out of existence. Despite those challenges, pharmacies are doing incredible work, and I know how much residents across Newbury and West Berkshire value their expertise and care.
In September 2024, the Government commissioned the Lord Darzi report, which rightly acknowledged the huge potential of pharmacies within the NHS. Two years on, with a workforce eager to do all it can, that potential remains unfulfilled—not for a lack of experience and care, but because of a lack of investment from the centre. The 10-year health plan’s ambition to shift care from hospitals into communities is absolutely the right one, and pharmacies are the linchpin of that push. As their responsibilities continue to rise, so must the Government’s backing. Pharmacies have spent the last 10 years being squeezed to near breaking point; the next 10 and beyond must be different.
I therefore ask the Minister to launch a strategic review of medicine supply, including reforms needed to build domestic manufacturing capability, and to commit to an above-inflation multi-year funding settlement that allows pharmacies to continue to serve my constituents and millions of patients across the country for decades to come.